期刊文献+

蛋白质组学研究的相关技术进展 被引量:4

下载PDF
导出
摘要 蛋白质组学的特点是采用高分辨率的蛋白质分离手段,结合高效率的蛋白质鉴定技术,全景式地研究在各种特定情况下的蛋白质谱。本文就蛋白质组学研究中的双向聚丙烯酰胺凝胶电泳、质谱技术和蛋白质芯片技术的研究进展进行了综述。
出处 《生物学教学》 北大核心 2010年第3期4-5,共2页 Biology Teaching
  • 相关文献

参考文献10

  • 1O'Farrell PH. 1975. High resolutlon two dimensional electrophoresis of proteins. Journal of Biological Chemisty, 250(10) : 4007 -4021.
  • 2俞利荣,曾嵘,夏其昌.蛋白质组研究技术及其进展[J].生命的化学,1998,18(6):4-9. 被引量:41
  • 3Scheler C, Lamer S, Pan Z, et al. 1998. Peptide mass fingerprint sequence coverage from differently stained proteins on two - dimensional electrophoresis patterns by matrix assisted lasered esorption/ioniza- tion - mass spectrometry ( MALDI - MS) Electrophoresis, 19(3) : 918- 927.
  • 4功能蛋白质组学[J].生命的化学,1998,18(6):1-4. 被引量:48
  • 5Chaurand P, Fouchecourt S, DaGue BB, et al. Profiling and imaging proteins in the mouse epididymis by imaging mass spectrometry. Proteomics, 3 ( 11 ) : 2221 - 2239.
  • 6MacBeath G,Schreiber SL. 2000. Printing proteins as microarray for high - throughput function determination Science, 289 (5485) : 1760 - 1763.
  • 7Davies H, Lomas L, Austen B 1999. Profiling of amyloid beta peptide variants using SELDI protein chip arrays. Biotechniqnes, 27 ( 6 ) : 1258-1270.
  • 8Emi T, Idriss M, Chritina R. 2000. Chip interacts with diverse homeodomain proteins and potentiates bicoid activity in vivo. Proceedings of the National Academy of Sciences, 97 ( 6 ) : 2686 - 2691.
  • 9Fung ET, Thulasiraman V, Weinberger SR, et al. 2001. Protein biochip for differential profiling. Current Opinion in Biotechnology, 12(1) :65 -69.
  • 10胡志远,贺福初.蛋白质组研究进展[J].生物化学与生物物理进展,1999,26(3):202-205. 被引量:29

共引文献107

同被引文献44

  • 1Edgell T, Martin-Roussety G, Barker G, et al. Phase II bio- marker trial of a multimarker diagnostic for ovarian cancer [J]. J Cancer Res Clin Oncol,2010,136(7):1079-1088.
  • 2Kulasingam V, Pavlou MP, Diamandis EP. Integrating high-throughput technologies in the quest for effective bi- omarkers for ovarian cancer[ J]. Nat Rev Cancer,2010, 10(5 ) :371-378.
  • 3Lu R ,Sun M, Feng J, et al. Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer [ J ]. BMC cancer, 2011, 270( 11 ) :234-242.
  • 4Kothandaraman N, Bajic VB, Brendan PN, et al. E2F5 sta- tus significantly improves malignancy diagnosis of epitheli- al ovarian cancer [ J ]. BMC Cancer, 2010,64 ( 10 ) : 336- 342.
  • 5Andersen MR,Goff BA,Lowe KA,et al. Use of a Symptom Index,CA125, and HE 4 to predict ovarian cancer [ J ]. Gynecol Oncol, 2010,116 ( 3 ) :378-383.
  • 6Nobbenhuis MA, Bancroft E, Moskovic E, et al. Screening for ovarian cancer in women with varying levels of risk, u- sing annual tests, results in high recall for repeat screening tests [ J ]. Hered Cancer Clin Pract,2011,9 ( 11 ) : 1-6.
  • 7Gang He, Holcroft CA, Beauchamp MC, et al. Combination of serum biomarkers to differentiate malignant from benign ovarian tumours [ J ] Obstet Gynaecol Can, 2012,34 ( 6 ) : 567-574.
  • 8Nakamura K, Hongo A, Kodama J, et al. The pretreatment of maximum standardized uptake values (SUVmax) of the primary tumor is predictor for poor prognosis for patients with epithelial ovarian canner[ J]. Acta Medica Okayama, 2012,66( 1 ) :53-60.
  • 9Kobayashi H,Ooi H,Yamada Y,et al. Serum CA125 level before the development of ovarian cancer[ J ]. Int J Gynae- col Obstet ,2007,99 (2) :95-99.
  • 10Zhang Z, Yu Y, Xu F, eta|. Combining multiple serum tumor markers improves detection of stage I epithelial o- varian cancer [ J ]. Gynecol Oncol, 2007,107 ( 3 ) : 526- 531.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部